Chromatin structure and transcriptional regulation of the stem cell leukaemia (SCL) gene in mast cells

Leukemia

Volumn 13, Issue 5, 1999, Pages 750-759

  Fordham, J L ^a   Gottgens B ^a   McLaughlin, F ^a   Green, A R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Hypersensitive sites; Mast cells; SCL gene

Indexed keywords

DEOXYRIBONUCLEASE I; RESTRICTION ENDONUCLEASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CHROMATIN STRUCTURE; HEMATOPOIETIC STEM CELL; LEUKEMIA; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TRANSCRIPTION REGULATION;

EID: 0344759186     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401420     Document Type: Article

References (51)

1. Begley CG, Aplan PD, Davey MP, Nakahara K, Tchorz K, Kurtzberg J, Hershfeld MS, Haynes BF, Cohen DI, Waldmann TA, Kirsch IR. Chromosomal translocation in a human leukemic stem cell line disrupts the T-cell antigen receptor δ-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 1989; 86: 2031-2035.
2. Finger LR, Kagan J, Christopher G, Kurtzberg J, Hershfield MS, Nowell PC, Croce C. Involvement of the TCL5 gene on chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 1989; 86: 5039-5043.
3. Bernard O, Guglielmi P, Jonveaux P, Cherif D, Gisselbrecht S, Mauchauffe M, Berger R, Larsen CJ, Mathieu-Mahul D. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosom Cancer 1990; 1: 194-208.
4. Chen Q, Cheng JT, Tsai LH, Schneider N, Buchanan G, Carroll A, Crist W, Ozanne B, Siciliano MJ, Baer R. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 1990; 9: 415-424.
5. Aplan PD, Raimondi SC, Kirsch IR. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J Exp Med 1992; 176: 1303-1310.
6. Baer R. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. Semin Cancer Biol 1993; 4: 341-347.
7. Condorelli GL, Facchiano F, Valtieri M, Proietti E, Vitelli L, Lulli V, Huebner K, Peschle C, Croce CM. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res 1996; 56: 5113-5119.
8. Kelliher MA, Seldin DC, Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J 1996; 15: 5160-5166.
9. Aplan PD, Jones CA, Chervinsky DS, Zhao XF, Ellsworth M, Wu CZ, McGuire EA, Gross KW. An scl gene product lacking the trans-activation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J 1997; 16: 2408-2419.
10. Larson RC, Lavenir I, Larson TA, Baer R, Warren AJ, Wadman I, Nottage K, Rabbitts TH. Protein dimerization between Lmo2 (Rbtn2) and Tall alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J 1996; 15: 1021-1027.
11. Bockamp E-O, McLaughlin F, Murrell AM, Göttgens B, Robb L, Begley CG, Green AR. Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood 1995; 86: 1502-1514.
12. Bockamp EO, McLaughlin F, Göttgens B, Murrell AM, Elefanty AG, Green AR. Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells. J Biol Chem 1997; 272: 8781-8790.
13. Bockamp E-O, Fordham JL, Gottgens B, Murrell AM, Sanchez M-J, Green AR. Transcriptional regulation of the stem cell leukaemia gene by PU.1 and E1f-1. j Biol Chem 1998; 273: 29032-29042.
14. Bernard O, Azogui O, Lecointe N, Mugneret F, Berger R, Larsen CJ, Mathieu-Mahul D. A third tal-1 promoter is specifically used in human T cell leukaemias. J Exp Med 1992; 176: 919-925.
15. Visvader J, Begley CG, Adams JM. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene 1991; 6: 195-204.
16. Green AR, Visvader J, Lints T, Harvey R, Begley CG. SCL is coexpressed with GATA-1 in haemopoietic cells but is also expressed in developing brain. Oncogene 1992; 7: 653-660.
17. Mouthon M-A, Bernard O, Mitjavila M-T, Romeo P-H, Vainchenker W, Mathieu-Mahul D. Expression of Tal-1 and GATA-binding proteins during human hematopoiesis. Blood 1993; 81: 647-655.
18. Green AR, Salvaris E, Begley CG. Erythroid expression of the 'helix-loop-helix' gene, SCL. Oncogene 1991; 6: 475-479.
19. Kallianpur AR, Jordan JE, Brandt SJ. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 1994; 83: 1200-1208.
20. Pulford K, Lecointe N, Leroy-Viard K, Jones M, Mathieu-Mahul D, Mason DY. Expression of TAL-1 proteins in human tissues. Blood 1995; 85: 675-684.
21. Green AR, De Luca E, Begley CG. Antisense SCL suppresses self-renewal and enhances spontaneous erythroid differentiation of the human leukaemic cell line K562. EMBO J 1991; 10: 4153-4158.
22. Aplan PD, Nakahra K, Orkin SH, Kirsch IR. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J 1992; 11: 4073-4081.
23. Tanigawa T, Elwood N, Metcalf D, Cary D, DeLuca E, Nicola NA. The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proc Natl Acad Sci USA 1993; 90: 7864-7868.
24. Cross MA, Heyworth CM, Murrell AM, Bockamp E-O, Cobley UT, Dexter TM, Green AR. Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogene 1994; 9: 3013-3016.
25. Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L, Valtieri M, Croce CM, Peschle C. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: Proliferative and anti-apoptotic effects coupled with a differentiation blockade. Mol Cell Biol 1997; 17: 2954-2969.
26. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature 1995; 373: 432-434.
27. Robb L, Lyons I, Li R, Hartley L, Kontgen F, Harvey RP, Metcalf D, Begley CG. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci USA 1995; 92: 7075-7079.
28. Robb L, Elwood NJ, Elefanty AG, Königen F, Li R, Barnett LD, Begley CG. The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 1996; 15: 4123-4129.
29. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 1996; 86: 47-57.
30. Gering M, Rodaway ARF, Gottgens B, Patient RK, Green AR. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J 1998; 17: 4029-4045.
31. Visvader JE, Fujiwara Y, Orkin SH. Unsuspected role for the T-cell leukaemia protein SCL/tal-1 in vascular development. Genes Dev 1998; 12: 473-479.
32. Liao EC, Paw BH, Oates AC, Pratt SJ, Postlethwait JH, Zon LI. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev 1998; 12: 621-626.
33. Göttgens B, McLaughlin F, Bockamp EO, Fordham JL, Begley CG, Kosmopoulos K, Elefanty AG, Green AR. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements. Oncogene 1997; 15: 2419-2428.
34. Galli SJ. New concepts about mast cells. New Engl J Med 1993; 328: 257-265.
35. Marone G, Casolaro V, Patella V, Florio G, Triggiani M. Molecular and cellular biology of mast cells and basophils. Int Arch Allergy Immunol 1997; 114: 207-217.
36. Henkel G, Brown MA. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci USA 1994; 91: 7737-7741.
37. Zon LI, Gurish MF, Stevens RL, Mather C, Reynolds DS, Austen KF, Orkin SH. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase a gene. J Biol Chem 1991; 266: 22948-22953.
38. Miyajima I, Levit L, Hara T, Bedell MA, Copeland NG, Jenkins NA, Miyajima A. The murine interleukin-3 receptor α subunit gene: chromosomal localization, genomic structure, and promoter function. Blood 1995; 5: 1246-1253.
39. Liao Y, Yi TL, Hoit BD, Walsh RA, Karnik SS, Husain A. Selective reporter expression in mast cells using a chymase promoter. J Biol Chem 1997; 272: 2969-2976.
40. Oh CK, Neurath M, Cho J-J, Semere T, Metcalfe DD. Two different regulatory elements control the transcription of T-cell activation gene 3 in activated mast cells. Biochem J 1997; 323: 511-519.
41. Morii E, Tsujimura T, Jippo T, Hashimoto K, Takebayashi K, Tsujino K, Nomura S, Yamamoto M, Kitimura Y. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood 1996; 7: 2488-2494.
42. Weiss DL, Hural J, Tara D, Timmerman LA, Henkel C, Brown M. Nuclear factor of activated T cells is associated with mast cell interleukin 4 transcription complex. Mol Cell Biol 1996; 16: 228-235.
43. Elefanty AG, Cory S. BCR-ABL-induced cell-lines can switch from mast-cell to erythroid or myeloid differentiation in vitro. Blood 1992; 79: 1271-1281.
44. Lecointe N, Bernard O, Naert K, Joulin V, Larsen CJ, Romeo PH, Mathieu-Mahul D. GATA-and SPI-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene 1994; 9: 2623-2632.
45. Boyes J, Felsenfeld G. Tissue-specific factors additively increase the probability of the all-or-none formation of a hypersensitive site. EMBO J 1996; 15: 2496-2507.
46. Leroy-Viard K, Vinit M-A, Lecointe N, Mathieu-Mahul D, Romeo P-H. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines. Blood 1994; 84: 3819-3827.
47. Begley CG, Robb L, Rockman S, Visvader J, Bockamp E-O, Chan YS, Green AR. Structure of the gene encoding the murine SCL protein. Gene 1994; 138: 93-99.
48. Merika M, Orkin SH. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol 1995; 15: 2437-2447.
49. Crossley M, Merika M, Orkin SH. Self-association of the erythroid transcription factor GATA-1 mediated by its zinc-finger domains. Mol Cell Biol 1995; 15: 2448-2456.
50. Gregory RC, Taxman DJ, Seshasayee D, Kensinger MH, Bieker JJ, Wojchowski DM. Functional interaction of GATA-1 with erythroid Kruppel-like factor and SP1 at defined erythroid promoters. Blood 1996; 87: 1793-1801.
51. Green AR. Hematopoiesis - master regulator unmasked. Nature 1996; 383: 575-577.